#foundayo — Public Fediverse posts

https://www.europesays.com/dk/127219/ Novo Nordisk CEO Dustar: Obesity Has Eclipsed Diabetes at ADA as Lilly’s Retatrutide Hits 28.3% Weight Loss — BigGo Finance #AmericanDiabetesAssociation #Amgen #atumelnant #BoehringerIngelheim #CrineticsPharmaceuticals #EliLilly #FDA #Foundayo #MaridebartCafraglutide #MichaelDustar #NovoNordisk #Pelsonify #RachelBatterham #retatrutide #VertexPharmaceuticals

https://www.europesays.com/britain/62024/ Encouraging trial results for AstraZeneca’s new weight-loss pill #AppetiteSuppressingDrugs #AstraZeneca #DiabetesTreatments #elecoglipron #ELILILLY #FOUNDAYO #Glp1Drugs #LancetMedicalJournal #Mounjaro #NovoNordisk #ObesityTreatment #OralDrugs #PharmaceuticalCompetition #Phase2Trial #UniversityOfCambridge #Wegovy #WeightLossMarket #WeightManagement #WeightLossPill

https://www.europesays.com/dk/76609/ Novo sees comeback as weight-loss pill boom revives investor confidence – Firstpost #DenmarkPharma #EliLilly #Foundayo #GLP1Drugs #HealthcareStocks #NovoNordisk #NovoShares #ObesityDrugs #ObesityTreatmentMarket #ozempic #PeptideTherapies #PharmaNews #WegovyPill #WeightLossDrugCompetition #WeightLossPill

https://www.europesays.com/dk/75598/ Novo Nordisk Share Price: Obesity Pill Ka Craze Hai, Par Profitability Ki Testing Shuru! #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket

https://www.europesays.com/dk/75448/ Novo Nordisk’s Obesity Pill Demand Soars, Profitability Faces Tough Test #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket

https://www.europesays.com/dk/69223/ Novo Nordisk’s Oral Pill Crushes Lilly’s Foundayo in Prescription Race, but a 50% Stock Rout Tel #Crushes #Foundayo #Lillys #Nordisk’s #novo #NovoNordisk #Oral #pill #prescription #race #stock

Eli Lilly's Oral Weight-Loss Drug Sees Initial Uptake Amidst Regulatory Scrutiny

Eli Lilly's new oral weight-loss drug Foundayo had 1,400 prescriptions in its first week. The FDA is checking its safety. Find out who is affected.

#Foundayo, #EliLilly, #WeightLossDrug, #FDASafety, #Orforglipron

https://newsletter.tf/eli-lilly-foundayo-drug-fda-safety-checks/

Eli Lilly's Foundayo drug received nearly 1,400 prescriptions in its first week, showing strong initial demand. This is a new oral option for weight loss.

#Foundayo, #EliLilly, #WeightLossDrug, #FDASafety, #Orforglipron
https://newsletter.tf/eli-lilly-foundayo-drug-fda-safety-checks/

https://www.europesays.com/hu/49364/ Újabb testsúlycsökkentő gyógyszert engedélyeztek az Egyesült Államokban #DavidRicks #egészségügy #ÉlelmiszerésGyógyszerügyiHatóság #EliLilly #fda #Foundayo #GLP1TípusúGyógyszerek #gyógyszeripar #Hungarian #LillyDirectProgram #Magyar #News #NovoNordisk #ÖbölMentiállamok #orforglipron #TestsúlycsökkentőTabletta #Világ #Wegovy #World #WorldNews